黃威翰 醫師

醫師代碼：25030

專 長

．一般內科

．血液疾病

．血癌

．淋巴癌

．造血幹細胞移植

．細胞治療

．臨床病理與檢驗醫學

．輸血醫學

現 職

花蓮慈濟醫院 臨床病理部 主任

花蓮慈濟醫院 血液腫瘤科 主治醫師

花蓮慈濟醫院 幹細胞與精準醫療研發中心免疫治療科 副主任

醫療財團法人台北捐血中心花蓮捐血站 顧問醫師

中華民國血液病學會 理事、 編輯委員會召集委員、臨床試驗委員會委員、多發性骨髓瘤工作組副召集人，良性血液病工作組委員

中華民國骨髓移植學會 學術委員會委員、甄審委員會委員、醫療對策委員會委員

學 歷

慈濟大學醫學系 

慈濟大學醫學科學研究所 博士班 博士候選人

經 歷

花蓮慈濟醫院 內科部住院醫師

國立臺灣大學醫學院附設醫院 檢驗醫學部住院醫師/總醫師

花蓮慈濟醫院 內科部住院總醫師

國立臺灣大學醫學院附設醫院 內科部血液科臨床研究醫師

專科證書

內科專科醫師證書

臨床病理專科醫師證書

血液病專科醫師證書

血液及骨髓移植專科醫師證書

專科學會

台灣醫學會、台灣內科醫學會、台灣臨床病理檢驗醫學會、台灣輸血學會、

中華民國血液病學會、中華民國血液及骨髓移植學會、台灣血栓暨止血學會

獲獎及其他榮譽

 95 年花蓮慈濟醫院優良員工

 96 年花蓮慈濟醫院最佳教學住院醫師

106年花蓮縣社會優秀青年

112年花蓮縣醫師公會優良醫師

著 作

1. Oral iptacopan monotherapy in paroxysmal nocturnal hemoglobinuria. Peffault de Latour R, Röth A, Kulasekararaj AG, Han B, Scheinberg P, Maciejewski JP, Ueda Y, de Castro CM, Di Bona E, Fu R, Zhang L, Griffin M, Langemeijer SMC, Panse J, Schrezenmeier H, Barcellini W, Mauad VAQ, Schafhausen P, Tavitian S, Beggiato E, Chew LP, Gaya A, Huang WH, Jang JH, Kitawaki T, Kutlar A, Notaro R, Pullarkat V, Schubert J, Terriou L, Uchiyama M, Wong Lee Lee L, Yap ES, Sicre de Fontbrune F, Marano L, Alashkar F, Gandhi S, Trikha R, Yang C, Liu H, Kelly RJ, Höchsmann B, Kerloeguen C, Banerjee P, Levitch R, Kumar R, Wang Z, Thorburn C, Maitra S, Li S, Verles A, Dahlke M, Risitano AM. Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2024 Mar 14;390(11):994-1008.
2. Momordica Anti-HIV Protein Map30 Abrogates the Persistent Infection of an Oncogenic Human Herpesvirus in Host Cell. Huang WH, Peng CW et al. Heliyon 2023 Nov; 9(11):e21486 (doi: 10.1016/j.heliyon.2023.e21486)
3. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies. Song YQ, Wu SJ, Shen ZX, Zhao DL, Chan SY, Huang HQ, Qui LG, Li JY, Tan TD, Zhu J, Song YP, Huang WH, Zhao WL, Liu SY, Xu W, Chen NZ, Ma J. Chang CS, Tse EWC, Exp Hematol Oncol. 2023 Oct 16; 12(1):92-117 (doi: 10.1186/s40164-023-00448-5)
4. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study. Wu YF, Gu MH, Liu CZ, Huang WH, Chu SC, Wang TF. PLoS One 2022 Nov 21;17(11):e0278040.
5. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience. Chou SC, Chang YC, Liao CK, Chen TC, Sun KJ, Huang WH, Wu YF. Platelets 2022 May 19;33(4):531-535
6. The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma. Liu CD, Chang CC, Huang WH. Tzu Chi Medical Journal 2021 33(3):257-262.
7. Acute Myeloid Leukemia Transformation from Myelofibrosis Upon Remission of an Orbital Myeloid Sarcoma – A Case Report. Chen N. Lin CS, Hsu YH, Huang WH, Huang CT, Lee  YC.  International Medical Case Reports Journal 2021:14, 443-448
8. Autologous stem cell transplantation in a patient with systemic sclerosis-associated interstitial lung disease in Taiwan. Pan YJ, Huang WH, Su KY. Asian Pac J Allergy Immunol. 2021 Sep 5. doi: 10.12932/AP-080421-1108
9. High rate of invasive fungal infections after non-T cell depleted haploidentical allo-HSCT even under antifungal prophylaxis. Lien MY, Gau JP, Wang PN, Li SS, Dai MS, Chen TC, Hsieh PY, Chiou LW, Huang, WH, Liu YC & Ko BS. Bone Marrow Transplantation 2021;56, 1750-1753
10. Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential Thrombocytosis Shen CL, Hsieh TC, Wang TF,Huang WH, Chu SC, Wu YF. Front. Medicine 2021 Dec 16;8:736150. doi: 10.3389/fmed.2021.736150. eCollection 2021
11. Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor-mutated lung adenocarcinoma. Li CC, Lin CB, Chu SC, Huang WH, Lee JJ, Yang GG, Wang TF, Yu YF, Medicine (Baltimore). 2020 Jul 17; 99(29):e21275.
12. Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation. Chang CC, Liu CD, Pan SF, Huang WH, Peng CW, Hsu HJ, Tzu Chi Medical Journal 2020; 32(3): 245–253
13. Post-HSCT relapsed precursor B-cell ALL successfully salvaged by BiTE followed by consolidation CAR-T cell therapy: A report of two cases. Huang WH, Tong CR, Wu T, Lin YC, Li CC. Blood Cell Ther. 2020 Aug 4;3(4):71-73. doi: 10.31547/bct-2020-002. eCollection 2020 Nov 25.
14. Higher CD56+ or CD2+ lymphocyte percentage predicts poor steroid response in patients with immune thrombocytopenia. Wu YF, Huang WH, Gu MH, Lin SR, Chu SC, Wang TF, Li CC. Thrombosis Research 2019(183):63–68
15. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1. Shen CL*, Huang WH*, Hsu HJ, Yang JH, Peng CW. Antiviral Res. 2019 Apr;164:123-130. (* co-first author)
16. Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment. Wang TF, Chu SC, Lee JJ, Yang GG, Huang WH, Chang ET, Low T, Wu YF, Kao RH, Lin CB. Asia Pac J Clin Oncol. 2017 Aug;13(4):304-313.
17. Characteristics of Taiwanese patients of PNH in the international PNH registry. Chou WC, Huang WH, Wang MC, Chang CS, Yeh SP, Chiou TJ, Chen YC, Lin TH, Shen MC & on behalf of the Taiwan PNH study group. Thromb J. 2016, 14(Suppl 1):39 p17-21
18. Thalidomide treatment in a myelofibrosis patient with leukemic transformation. Huang WH, Li MS, Chu SC, Wang TF, Kao RH, Wu YF.  Int J Hematol (2014) 99:188–192
19. Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: MIC Matters. Lee NY, Lee CC, Huang WH, Tsui KC, Hsueh PR, Ko WC. Clin Infect Dis. 2013 Feb;56(4):488-95
20. Carbapenem therapy for bacteremia due to extended- spectrum- β-lactamase- producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility. Lee NY, Lee CC, Huang WH, Tsui KC, Hsueh PR, Ko WC. Antimicrob Agents Chemother. 2012 Jun;56(6):2888-93.
21. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community. Lee JC, Lee NY, Lee HC, Huang WH, Tsui KC, Chang CM, Lee CC, Chen PL, Wu CJ, Hsueh PR, Ko WC. J Microbiol Immunol Infect. 2012 Apr;45(2):127-33.
22. Non-carriers of reduced-function CYP2C19 alleles are most susceptible to the impairment of the antiplatelet effect of clopidogrel by concomitant use of proton-pump inhibitor. Lee JK, Huang WH, Chiang FT. Eur Heart J. 2010 Sep;31(supp1):619.
23. 臨床鏡檢學圖譜，第二版 2011.10 朱蘇煜、林啟萬、塑谷賢一、橫山貴、林雯志、柯建興、姜至剛、李任光、黃威翰 ISBN-13: 978-957-41-8579-5

T